CIK 0001401914
- Non-accelerated filer
- Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 204139823
- Phone
- +1 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-26 | Hall Steven Edward Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2014-04-15 | Hall Steven Edward Director | Conversion | +931,485 | 931,485 | ||
| 2014-04-15 | Hall Steven Edward Director | Conversion | +299,213 | 1,230,698 | ||
| 2014-04-15 | Hall Steven Edward Director | Conversion | +192,209 | 1,422,907 | ||
| 2014-04-15 | Hall Steven Edward Director | Conversion | +199,875 | 1,622,782 | ||
| 2014-04-15 | Hall Steven Edward Director | Purchase | +733,445 | $7.00 | $5.1M | 2,356,227 |
| 2014-04-15 | Hall Steven Edward Director | Conversion · Series C Convertible Preferred Stock | −13,513,513 | 0 | ||
| 2014-04-15 | Hall Steven Edward Director | Conversion · Series D Convertible Preferred Stock | −4,340,831 | 0 | ||
| 2014-04-15 | Hall Steven Edward Director | Conversion · 7% Convertible Promissory Notes | −0 | 0 | ||
| 2014-04-15 | Hall Steven Edward Director | Conversion · 7% Convertible Promissory Notes | −0 | 0 |
Page 1 of 1 · 10 trades